Apollo Medical - AMEH Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12-month price targets for Apollo Medical's shares. Their AMEH share price forecasts range from $57.00 to $57.00. On average, they predict the company's share price to reach $57.00 in the next year. This suggests a possible upside of 19.6% from the stock's current price.
View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts.

Apollo Medical's stock was trading at $73.48 at the beginning of the year. Since then, AMEH shares have decreased by 35.2% and is now trading at $47.64.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our AMEH earnings forecast.

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating the consensus estimate of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a net margin of 7.72% and a trailing twelve-month return on equity of 15.80%. During the same quarter in the prior year, the firm earned $0.45 EPS.

Apollo Medical issued an update on its FY 2022 earnings guidance on Thursday, August, 18th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.05 billion-$1.08 billion, compared to the consensus revenue estimate of $1.06 billion.

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Apollo Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include State Street Corp (2.26%), Northern Trust Corp (0.73%), Atria Wealth Solutions Inc. (0.68%), Principal Financial Group Inc. (0.43%), Steel Peak Wealth Management LLC (0.40%) and Point72 Asset Management L.P. (0.35%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Kenneth T Sim, Linda Marsh, Michael F Eng, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends.

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AMEH stock can currently be purchased for approximately $47.64.

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.69 billion and generates $773.91 million in revenue each year. The company earns $73.86 million in net income (profit) each year or $1.60 on an earnings per share basis.

The company employs 1,133 workers across the globe.

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 943-6491, via email at investors@apollomed.net, or via fax at 818-839-5190.